U.S. Markets closed

GlaxoSmithKline’s Vaccine Business in 1Q18

Mike Benson
GlaxoSmithKline’s Vaccine Business in 1Q18

GlaxoSmithKline’s (GSK) Vaccine business includes vaccines for meningitis, influenza, and shingles as well as established vaccines. GlaxoSmithKline had acquired meningitis vaccines from Novartis (NVS) in 2016.